Literature DB >> 26833758

Orosomucoid (ORM) as a Potential Biomarker for the Diagnosis of Chronic Fatigue Syndrome (CFS).

Yang Sun1, Zhen-Xian Zhang2, Xia Liu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26833758      PMCID: PMC6492840          DOI: 10.1111/cns.12522

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  2 in total

1.  Orosomucoid: a promising biomarker for the assessment of exercise-induced fatigue triggered by basic combat training.

Authors:  Yi Ruan; Ke-Fa Xiang; Hui-Min Zhang; Zhen Qin; Yang Sun; Jing-Jing Wan; Wei Gu; Xia Liu
Journal:  BMC Sports Sci Med Rehabil       Date:  2022-06-03

2.  Estrogen weakens muscle endurance via estrogen receptor-p38 MAPK-mediated orosomucoid (ORM) suppression.

Authors:  Yang Sun; Zhen Qin; Jing-Jing Wan; Peng-Yuan Wang; Yi-Li Yang; Jian-Guang Yu; Bo-Han Hu; Ding-Feng Su; Zhu-Min Luo; Xia Liu
Journal:  Exp Mol Med       Date:  2018-03-30       Impact factor: 8.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.